中天火箭：2025年前三季度净利润约-2938万元

Group 1 - The core point of the article is that Zhongtian Rocket reported a significant decline in revenue and incurred a net loss in its third-quarter earnings announcement for 2025 [1] - For the first three quarters of 2025, the company's revenue was approximately 444 million yuan, representing a year-on-year decrease of 30.95% [1] - The net profit attributable to shareholders was a loss of approximately 29.38 million yuan, with a basic earnings per share loss of 0.1891 yuan [1] Group 2 - As of the report, Zhongtian Rocket's market capitalization was 8.2 billion yuan [2] - The article also highlights the booming secondary market for biopharmaceuticals in China, with overseas licensing deals reaching 80 billion US dollars this year [2] - There is a contrast noted between the hot secondary market and the cold fundraising environment in the primary market for biopharmaceuticals [2]